tiprankstipranks
Keros Therapeutics, Inc. (KROS)
NASDAQ:KROS
US Market
KROS
Keros Therapeutics
RESEARCH TOOLSreports

Keros Therapeutics (KROS) Balance Sheet

362 Followers

Keros Therapeutics Balance Sheet

Keros Therapeutics's total assets for Q4 2025 were $338.02M, a decrease of -54.49% from the previous quarter. KROS total liabilities were $34.89M for the fiscal quarter, a -11.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 338.02M$ 615.89M$ 370.02M$ 306.78M$ 255.25M
Total Liabilities
$ 34.89M$ 44.33M$ 37.81M$ 29.36M$ 12.08M
Total Equity Gross Minority
$ 303.13M$ 571.55M$ 332.21M$ 277.42M$ 243.17M
Other Metrics
Currency in USD

Keros Therapeutics Debt to Assets